Pharmacology and toxicology are complementary disciplines studying the beneficial and harmful effects of chemical agents on living systems. Pharmacology explores drug actions, mechanisms, and therapeutic uses, while toxicology assesses potential hazards and safety thresholds. Together, they guide the drug development pipeline from discovery to post-market surveillance. The integration of molecular biology, biochemistry, and pathophysiology allows for a deeper understanding of drug–body interactions. Research in these fields addresses critical healthcare challenges, including adverse effects, drug resistance, and environmental exposures. Advances in these sciences ensure the development of safe, effective, and sustainable therapies for global health needs.

Subtracts:

• Fundamentals and Scope of Pharmacology and Toxicology
• Drug–Receptor Interactions and Mechanisms of Action
• Dose–Response Relationships and Safety Margins
• Preclinical and Clinical Safety Evaluations
• Translational Approaches in Drug Safety

Related Conferences:
World Congress on Pharmacology & Toxicology (WCPT) | International Conference on Clinical Pharmacology & Therapeutics (ICCPT) | Global Summit on Drug Discovery and Development (GSDDD) | European Conference on Toxicology & Applied Pharmacology (ECTAP) | International Symposium on Experimental and Clinical Toxicology (ISECT)

Related Associations:
International Union of Basic and Clinical Pharmacology (IUPHAR) | British Pharmacological Society (BPS) | American Society for Pharmacology and Experimental Therapeutics (ASPET) | European Society of Toxicology (EUROTOX) | Society of Toxicology (SOT) | Asia Pacific Association of Pharmacologists (APAP) | Federation of Asian Pharmacological Societies (FAPS) | International Society for the Study of Xenobiotics (ISSX)

Pharmacokinetics (PK) studies how the body absorbs, distributes, metabolizes, and eliminates drugs, while pharmacodynamics (PD) examines the biochemical and physiological effects of drugs and their mechanisms of action. Together, PK/PD modeling is essential for determining optimal dosing regimens, predicting therapeutic outcomes, and minimizing toxicity. These principles form the foundation for drug development, clinical trials, and personalized therapy. Modern research focuses on integrating PK/PD data with pharmacogenomics to improve patient outcomes and address variability in drug response. Understanding PK and PD helps bridge laboratory findings with clinical applications for more precise and effective treatments.

Subtracts:

• ADME (Absorption, Distribution, Metabolism, and Excretion) Studies
• PK/PD Modelling and Simulation
• Drug Half-life and Bioavailability Assessments
• Relationship Between Concentration and Effect
• Clinical Applications of PK/PD Principles

Related Conferences:
World Congress on Pharmacology & Toxicology (WCPT) | International Conference on Clinical Pharmacology & Therapeutics (ICCPT) | Global Summit on Drug Discovery and Development (GSDDD) | European Conference on Toxicology & Applied Pharmacology (ECTAP) | International Symposium on Experimental and Clinical Toxicology (ISECT)

Related Associations:
International Union of Basic and Clinical Pharmacology (IUPHAR) | British Pharmacological Society (BPS) | American Society for Pharmacology and Experimental Therapeutics (ASPET) | European Society of Toxicology (EUROTOX) | Society of Toxicology (SOT) | Asia Pacific Association of Pharmacologists (APAP) | Federation of Asian Pharmacological Societies (FAPS) | International Society for the Study of Xenobiotics (ISSX)

Drug discovery and development encompass the identification of new therapeutic compounds, their optimization, and the evaluation of their safety and efficacy. This multi-stage process involves target identification, hit-to-lead optimization, preclinical testing, and phased clinical trials. Advanced computational methods, high-throughput screening, and artificial intelligence are revolutionizing the drug discovery pipeline. The development stage focuses on translating laboratory findings into clinically viable drugs through rigorous testing and regulatory compliance. Current trends emphasize precision medicine, repurposing of existing drugs, and sustainable manufacturing practices. Effective collaboration among academia, industry, and regulatory agencies is key to accelerating innovation.

Subtracts:

• Target Identification and Validation
• High-Throughput Screening and Lead Optimization
• Preclinical Studies and Translational Research
• Clinical Trial Design and Phases
• Drug Repurposing Strategies

Related Conferences:
World Congress on Pharmacology & Toxicology (WCPT) | International Conference on Clinical Pharmacology & Therapeutics (ICCPT) | Global Summit on Drug Discovery and Development (GSDDD) | European Conference on Toxicology & Applied Pharmacology (ECTAP) | International Symposium on Experimental and Clinical Toxicology (ISECT)

Related Associations:
International Union of Basic and Clinical Pharmacology (IUPHAR) | British Pharmacological Society (BPS) | American Society for Pharmacology and Experimental Therapeutics (ASPET) | European Society of Toxicology (EUROTOX) | Society of Toxicology (SOT) | Asia Pacific Association of Pharmacologists (APAP) | Federation of Asian Pharmacological Societies (FAPS) | International Society for the Study of Xenobiotics (ISSX)

Pharmaceutical biotechnology applies biological systems and living organisms to the development of drugs, vaccines, and diagnostic tools. This field integrates genetic engineering, cell culture technologies, and molecular biology to produce biopharmaceuticals such as monoclonal antibodies, recombinant proteins, and therapeutic enzymes. It plays a critical role in addressing complex diseases, including cancer, autoimmune disorders, and infectious diseases. Research focuses on optimizing production processes, ensuring biosafety, and improving delivery systems. Biotechnology also enables the development of biosimilar, expanding access to advanced therapies. Innovations in this field continue to reshape modern medicine by delivering targeted, effective, and safer treatments.

Subtracks:

• Recombinant DNA Technology in Drug Production
• Monoclonal Antibody Development
• Vaccine Design and Production
• Gene and Cell Therapies
• Bioprocess Optimization and Scale-Up

Related Conferences:
World Congress on Pharmacology & Toxicology (WCPT) | International Conference on Clinical Pharmacology & Therapeutics (ICCPT) | Global Summit on Drug Discovery and Development (GSDDD) | European Conference on Toxicology & Applied Pharmacology (ECTAP) | International Symposium on Experimental and Clinical Toxicology (ISECT)

Related Associations:
International Union of Basic and Clinical Pharmacology (IUPHAR) | British Pharmacological Society (BPS) | American Society for Pharmacology and Experimental Therapeutics (ASPET) | European Society of Toxicology (EUROTOX) | Society of Toxicology (SOT) | Asia Pacific Association of Pharmacologists (APAP) | Federation of Asian Pharmacological Societies (FAPS) | International Society for the Study of Xenobiotic (ISSX)

Biologic drugs are complex, large-molecule therapies derived from living cells, offering targeted treatment for a wide range of diseases. Biosimilar are highly similar versions of approved biologics, designed to match their safety, efficacy, and quality profiles. The development of biologics and biosimilar involves sophisticated manufacturing processes and strict regulatory oversight. These therapies have transformed treatment approaches for conditions such as rheumatoid arthritis, cancer, and multiple sclerosis. Research in this area aims to improve cost-effectiveness, expand patient access, and develop innovative delivery systems. Understanding the nuances of immunogenicity, manufacturing consistency, and clinical equivalence is vital for success in this field.

Subtracts:

• Development and Characterization of Biologics
• Regulatory Pathways for Biosimilar
• Clinical Comparability and Equivalence Studies
• Immunogenicity Assessment
• Market Access and Cost Considerations
•  

Related Conferences:
World Congress on Pharmacology & Toxicology (WCPT) | International Conference on Clinical Pharmacology & Therapeutics (ICCPT) | Global Summit on Drug Discovery and Development (GSDDD) | European Conference on Toxicology & Applied Pharmacology (ECTAP) | International Symposium on Experimental and Clinical Toxicology (ISECT)

Related Associations:
International Union of Basic and Clinical Pharmacology (IUPHAR) | British Pharmacological Society (BPS) | American Society for Pharmacology and Experimental Therapeutics (ASPET) | European Society of Toxicology (EUROTOX) | Society of Toxicology (SOT) | Asia Pacific Association of Pharmacologists (APAP) | Federation of Asian Pharmacological Societies (FAPS) | International Society for the Study of Xenobiotics (ISSX)

Pharmacovigilance is the science and practice of monitoring the safety of medicines throughout their lifecycle, from clinical trials to post-market use. It focuses on detecting, assessing, understanding, and preventing adverse effects or other drug-related problems. Effective pharmacovigilance systems protect public health by ensuring that the benefits of a medicine outweigh its risks. With the rise of biologics, combination therapies, and global drug distribution, robust safety monitoring is more important than ever. Digital health tools, big data analytics, and real-world evidence are enhancing early detection of safety signals. Collaboration between regulatory agencies, healthcare providers, and the pharmaceutical industry is essential to maintain patient safety.

Subtracts:

• Adverse Event Detection and Reporting Systems
• Risk Management Plans and Benefit–Risk Assessment
• Post-Marketing Surveillance and Signal Detection
• Role of Real-World Data in Safety Monitoring
• International Regulatory Frameworks for Pharmacovigilance

Related Conferences:
World Congress on Pharmacology & Toxicology (WCPT) | International Conference on Clinical Pharmacology & Therapeutics (ICCPT) | Global Summit on Drug Discovery and Development (GSDDD) | European Conference on Toxicology & Applied Pharmacology (ECTAP) | International Symposium on Experimental and Clinical Toxicology (ISECT)

Related Associations:
International Union of Basic and Clinical Pharmacology (IUPHAR) | British Pharmacological Society (BPS) | American Society for Pharmacology and Experimental Therapeutics (ASPET) | European Society of Toxicology (EUROTOX) | Society of Toxicology (SOT) | Asia Pacific Association of Pharmacologists (APAP) | Federation of Asian Pharmacological Societies (FAPS) | International Society for the Study of Xenobiotics (ISSX)

Nano medicine applies nanoscale technologies to diagnose, treat, and prevent diseases, offering targeted delivery systems and improved therapeutic efficacy. Nanoparticles can enhance drug solubility, stability, and controlled release, reducing side effects and improving patient outcomes. Nanotechnology also plays a role in advanced imaging, biosensors, and regenerative medicine. Research in this field is expanding into personalized Nano medicine, cancer therapy, and antimicrobial treatments. Safety assessment, manufacturing scalability, and regulatory approval remain key considerations for clinical translation. The potential of Nano medicine lies in its ability to revolutionize diagnostics and therapies by working at the molecular and cellular levels.

subtracts:

• Nano carriers for Targeted Drug Delivery
• Nano formulations in Cancer Therapy
• Nano diagnostics and Biosensors
• Nanoparticles in Regenerative Medicine
• Safety and Regulatory Aspects of Nano medicine

Related Conferences:
World Congress on Pharmacology & Toxicology (WCPT) | International Conference on Clinical Pharmacology & Therapeutics (ICCPT) | Global Summit on Drug Discovery and Development (GSDDD) | European Conference on Toxicology & Applied Pharmacology (ECTAP) | International Symposium on Experimental and Clinical Toxicology (ISECT)

Related Associations:
International Union of Basic and Clinical Pharmacology (IUPHAR) | British Pharmacological Society (BPS) | American Society for Pharmacology and Experimental Therapeutics (ASPET) | European Society of Toxicology (EUROTOX) | Society of Toxicology (SOT) | Asia Pacific Association of Pharmacologists (APAP) | Federation of Asian Pharmacological Societies (FAPS) | International Society for the Study of Xenobiotics (ISSX)

The route of drug administration determines how a medicine enters the body, affecting its absorption, distribution, metabolism, and excretion. Routes can be systemic (oral, intravenous, intramuscular) or local (topical, inhalational, transdermal), each with advantages and limitations. Choosing the optimal route depends on drug properties, desired onset of action, patient compliance, and treatment objectives. Research focuses on novel delivery systems such as microneedles, inhalable nanoparticles, and implantable devices to enhance bioavailability and patient convenience. Understanding pharmacokinetics and formulation science is essential for optimizing drug delivery and therapeutic outcomes.

subtracts:

• Oral and Parenteral Drug Delivery Systems
• Transdermal and Topical Applications
• Inhalation Therapies and Pulmonary Delivery
• Implantable and Controlled-Release Systems
• Innovations in Non-Invasive Drug Delivery
•  

Related Conferences:
World Congress on Pharmacology & Toxicology (WCPT) | International Conference on Clinical Pharmacology & Therapeutics (ICCPT) | Global Summit on Drug Discovery and Development (GSDDD) | European Conference on Toxicology & Applied Pharmacology (ECTAP) | International Symposium on Experimental and Clinical Toxicology (ISECT)

Related Associations:
International Union of Basic and Clinical Pharmacology (IUPHAR) | British Pharmacological Society (BPS) | American Society for Pharmacology and Experimental Therapeutics (ASPET) | European Society of Toxicology (EUROTOX) | Society of Toxicology (SOT) | Asia Pacific Association of Pharmacologists (APAP) | Federation of Asian Pharmacological Societies (FAPS) | International Society for the Study of Xenobiotics (ISSX)

Clinical and medical pharmacology focus on the scientific study and practical application of drugs in human health and disease. This discipline bridges laboratory research with patient care, ensuring that medications are used safely, effectively, and appropriately. Clinical pharmacologists work on optimizing dosing regimens, managing drug interactions, and tailoring therapy to individual patient needs. They also contribute to clinical trials, regulatory evaluations, and post-marketing monitoring. Advances in biomarker research, therapeutic drug monitoring, and pharmacogenomics are transforming clinical practice. The goal is to maximize therapeutic benefit while minimizing adverse outcomes in diverse patient populations.

sub tracks:

• Principles of Clinical Pharmacology
• Therapeutic Drug Monitoring
• Management of Drug Interactions
• Role in Clinical Trial Design and Evaluation
• Personalized Medicine in Clinical Practice
•  

Related Conferences:
World Congress on Pharmacology & Toxicology (WCPT) | International Conference on Clinical Pharmacology & Therapeutics (ICCPT) | Global Summit on Drug Discovery and Development (GSDDD) | European Conference on Toxicology & Applied Pharmacology (ECTAP) | International Symposium on Experimental and Clinical Toxicology (ISECT)

Related Associations:
International Union of Basic and Clinical Pharmacology (IUPHAR) | British Pharmacological Society (BPS) | American Society for Pharmacology and Experimental Therapeutics (ASPET) | European Society of Toxicology (EUROTOX) | Society of Toxicology (SOT) | Asia Pacific Association of Pharmacologists (APAP) | Federation of Asian Pharmacological Societies (FAPS) | International Society for the Study of Xenobiotics (ISSX)

Pharmacokinetics and pharmacogenomics study how genetic variations influence an individual's response to drugs. While pharmacokinetics focuses on single-gene effects, pharmacogenomics considers the impact of the entire genome. These fields enable personalized therapy by predicting drug efficacy, optimal dosing, and risk of adverse reactions. Advances in genetic testing and bioinformatics are making personalized medicine more accessible. Research applications range from oncology to psychiatry, where genetic profiles guide treatment selection. Ethical, regulatory, and cost considerations remain important as these approaches integrate into routine clinical practice.

sub tracks:

• Genetic Variations in Drug-Metabolizing Enzymes
• Pharmacogenomics Biomarkers in Therapy Selection
• Genomic Approaches to Adverse Drug Reactions
• Integration into Clinical Decision-Making
• Ethical and Regulatory Considerations in Pharmacogenomics

Related Conferences:
World Congress on Pharmacology & Toxicology (WCPT) | International Conference on Clinical Pharmacology & Therapeutics (ICCPT) | Global Summit on Drug Discovery and Development (GSDDD) | European Conference on Toxicology & Applied Pharmacology (ECTAP) | International Symposium on Experimental and Clinical Toxicology (ISECT)

Related Associations:
International Union of Basic and Clinical Pharmacology (IUPHAR) | British Pharmacological Society (BPS) | American Society for Pharmacology and Experimental Therapeutics (ASPET) | European Society of Toxicology (EUROTOX) | Society of Toxicology (SOT) | Asia Pacific Association of Pharmacologists (APAP) | Federation of Asian Pharmacological Societies (FAPS) | International Society for the Study of Xenobiotics (ISSX)

Environmental toxicology studies the harmful effects of chemical, biological, and physical agents on living organisms and ecosystems. It examines exposure pathways, toxic mechanisms, and long-term environmental and health impacts. Pollutants such as pesticides, heavy metals, and industrial chemicals can accumulate in soil, water, and air, posing risks to both wildlife and humans. Research aims to understand dose–response relationships, bioaccumulation, and ecosystem resilience. Environmental toxicologists also contribute to risk assessment, policy-making, and remediation strategies. As global industrialization continues, managing environmental pollutants is a critical public health priority.

sub tracks:

• Ecotoxicology and Ecosystem Impact Assessments
• Bioaccumulation and Bio magnification Studies
• Risk Assessment of Environmental Contaminants
• Remediation and Pollution Control Strategies
• Climate Change and Emerging Environmental Toxins

Related Conferences:
World Congress on Pharmacology & Toxicology (WCPT) | International Conference on Clinical Pharmacology & Therapeutics (ICCPT) | Global Summit on Drug Discovery and Development (GSDDD) | European Conference on Toxicology & Applied Pharmacology (ECTAP) | International Symposium on Experimental and Clinical Toxicology (ISECT)

Related Associations:
International Union of Basic and Clinical Pharmacology (IUPHAR) | British Pharmacological Society (BPS) | American Society for Pharmacology and Experimental Therapeutics (ASPET) | European Society of Toxicology (EUROTOX) | Society of Toxicology (SOT) | Asia Pacific Association of Pharmacologists (APAP) | Federation of Asian Pharmacological Societies (FAPS) | International Society for the Study of Xenobiotics (ISSX)

Pharmacoepidemiology applies epidemiological methods to study the use and effects of drugs in large populations. It provides essential data on drug safety, effectiveness, and patterns of utilization in real-world settings. By combining pharmacology and epidemiology, this field supports informed decision-making for healthcare policy, clinical guidelines, and risk management. Data sources include electronic health records, prescription databases, and patient registries. Current research focuses on evaluating long-term safety, comparative effectiveness, and rare adverse events. Pharmacoepidemiology also plays a crucial role in pharmacovigilance and health economics.

sub tracks:

• Drug Utilization Studies
• Comparative Effectiveness Research
• Risk–Benefit Assessment in Large Populations
• Data Sources and Methodologies in Pharmacoepidemiology
• Role in Health Policy and Regulation

Related Conferences:
World Congress on Pharmacology & Toxicology (WCPT) | International Conference on Clinical Pharmacology & Therapeutics (ICCPT) | Global Summit on Drug Discovery and Development (GSDDD) | European Conference on Toxicology & Applied Pharmacology (ECTAP) | International Symposium on Experimental and Clinical Toxicology (ISECT)

Related Associations:
International Union of Basic and Clinical Pharmacology (IUPHAR) | British Pharmacological Society (BPS) | American Society for Pharmacology and Experimental Therapeutics (ASPET) | European Society of Toxicology (EUROTOX) | Society of Toxicology (SOT) | Asia Pacific Association of Pharmacologists (APAP) | Federation of Asian Pharmacological Societies (FAPS) | International Society for the Study of Xenobiotics (ISSX)

Adverse drug reactions (ADRs) are unwanted or harmful effects resulting from the use of medications at normal doses. They range from mild side effects to life-threatening conditions and represent a major concern in clinical practice. Understanding the mechanisms, risk factors, and prevention strategies for ADRs is essential to patient safety. ADRs can result from allergic responses, drug–drug interactions, or genetic predispositions. Research emphasizes predictive models, improved reporting systems, and early detection through biomarkers. Clinicians and regulatory authorities work together to minimize the risk and impact of ADRs.

sub tracks:

• Classification and Mechanisms of ADRs
• Risk Factors and Patient Susceptibility
• Drug–Drug and Drug–Food Interactions
• Prevention and Management Strategies
• Pharmacovigilance in ADR Monitoring

Related Conferences:
World Congress on Pharmacology & Toxicology (WCPT) | International Conference on Clinical Pharmacology & Therapeutics (ICCPT) | Global Summit on Drug Discovery and Development (GSDDD) | European Conference on Toxicology & Applied Pharmacology (ECTAP) | International Symposium on Experimental and Clinical Toxicology (ISECT)

Related Associations:
International Union of Basic and Clinical Pharmacology (IUPHAR) | British Pharmacological Society (BPS) | American Society for Pharmacology and Experimental Therapeutics (ASPET) | European Society of Toxicology (EUROTOX) | Society of Toxicology (SOT) | Asia Pacific Association of Pharmacologists (APAP) | Federation of Asian Pharmacological Societies (FAPS) | International Society for the Study of Xenobiotics (ISSX)

Applied and regulatory toxicology focus on the practical use of toxicological data in policy-making, industry standards, and public health protection. Regulatory toxicologists evaluate safety data for chemicals, pharmaceuticals, and consumer products to ensure compliance with legal requirements. Applied toxicology translates laboratory findings into guidelines for occupational safety, environmental health, and product labeling. Research supports risk assessment, exposure limits, and hazard classification. This field bridges science with regulatory frameworks to protect both human health and the environment.

sub tracks:

• Toxicity Testing and Risk Assessment Methods
• Regulatory Guidelines for Pharmaceuticals and Chemicals
• Occupational and Workplace Safety Standards
• Consumer Product Safety Evaluation
• International Harmonization of Toxicology Regulations

Related Conferences:
World Congress on Pharmacology & Toxicology (WCPT) | International Conference on Clinical Pharmacology & Therapeutics (ICCPT) | Global Summit on Drug Discovery and Development (GSDDD) | European Conference on Toxicology & Applied Pharmacology (ECTAP) | International Symposium on Experimental and Clinical Toxicology (ISECT)

Related Associations:
International Union of Basic and Clinical Pharmacology (IUPHAR) | British Pharmacological Society (BPS) | American Society for Pharmacology and Experimental Therapeutics (ASPET) | European Society of Toxicology (EUROTOX) | Society of Toxicology (SOT) | Asia Pacific Association of Pharmacologists (APAP) | Federation of Asian Pharmacological Societies (FAPS) | International Society for the Study of Xenobiotics (ISSX)

Aquatic toxicology examines the effects of toxic substances on aquatic organisms, from microorganisms to fish and marine mammals. It studies how pollutants enter and move through aquatic ecosystems, as well as their short- and long-term impacts. Common contaminants include heavy metals, pesticides, pharmaceuticals, and microplastics. Research includes laboratory bioassays, field monitoring, and ecological modeling to understand exposure pathways and ecological risks. Aquatic toxicology also informs environmental regulations, water quality standards, and pollution control strategies. Preserving aquatic health is essential for biodiversity, fisheries, and human water resources.

sub tracks:

• Toxic Effects of Pollutants on Aquatic Life
• Bioaccumulation and Food Chain Transfer
• Water Quality Monitoring and Assessment
• Eco toxicological Modeling and Risk Prediction
• Mitigation and Restoration of Aquatic Ecosystems

Related Conferences:
World Congress on Pharmacology & Toxicology (WCPT) | International Conference on Clinical Pharmacology & Therapeutics (ICCPT) | Global Summit on Drug Discovery and Development (GSDDD) | European Conference on Toxicology & Applied Pharmacology (ECTAP) | International Symposium on Experimental and Clinical Toxicology (ISECT)

Related Associations:
International Union of Basic and Clinical Pharmacology (IUPHAR) | British Pharmacological Society (BPS) | American Society for Pharmacology and Experimental Therapeutics (ASPET) | European Society of Toxicology (EUROTOX) | Society of Toxicology (SOT) | Asia Pacific Association of Pharmacologists (APAP) | Federation of Asian Pharmacological Societies (FAPS) | International Society for the Study of Xenobiotics (ISSX)

Immunopharmacology studies how drugs affect the immune system, while immunotoxicology examines adverse effects on immune function caused by chemical or biological agents. This field covers immunomodulatory, vaccines, and monoclonal antibodies, as well as drug-induced immunosuppression or hypersensitivity reactions. It plays a critical role in treating autoimmune diseases, allergies, cancer, and infectious diseases. Immunotoxicology assesses risks such as immunosuppression, autoimmunity, or hypersensitivity from pharmaceuticals, environmental agents, or occupational exposures. Advances in biotechnology and immunotherapy are expanding the scope of both disciplines, requiring precise safety evaluation and regulatory oversight.

sub tracks:

• Immunomodulatory Drugs and Therapeutics
• Vaccine Pharmacology and Adjuvant Development
• Drug-Induced Immunosuppression and Hypersensitivity
• Immune Checkpoint Inhibitors in Cancer Therapy
• Immunotoxicity Risk Assessment and Regulatory Guidelines

Related Conferences:
World Congress on Pharmacology & Toxicology (WCPT) | International Conference on Clinical Pharmacology & Therapeutics (ICCPT) | Global Summit on Drug Discovery and Development (GSDDD) | European Conference on Toxicology & Applied Pharmacology (ECTAP) | International Symposium on Experimental and Clinical Toxicology (ISECT)

Related Associations:
International Union of Basic and Clinical Pharmacology (IUPHAR) | British Pharmacological Society (BPS) | American Society for Pharmacology and Experimental Therapeutics (ASPET) | European Society of Toxicology (EUROTOX) | Society of Toxicology (SOT) | Asia Pacific Association of Pharmacologists (APAP) | Federation of Asian Pharmacological Societies (FAPS) | International Society for the Study of Xenobiotics (ISSX)

Neuropsychopharmacology focuses on how drugs influence brain function, behavior, and mental health. It integrates neuroscience, psychiatry, and pharmacology to study treatments for psychiatric and neurological disorders. This includes antidepressants, antipsychotics, anxiolytics, mood stabilizers, and drugs for neurodegenerative diseases. The field also examines the neurobiological basis of addiction, cognition, and emotional regulation. Research combines molecular studies, brain imaging, and behavioral science to understand drug mechanisms and optimize therapy. Advances in personalized psychiatry and neuropharmacogenetics are opening new possibilities for targeted mental health treatments.

sub tracks:

• Pharmacotherapy for Depression, Anxiety, and Psychosis
• Neurotransmitter Systems and Drug Mechanisms
• Neurodegenerative Disease Treatments
• Addiction and Substance Use Disorder Pharmacology
• Brain Imaging in Drug Research

Related Conferences:
World Congress on Pharmacology & Toxicology (WCPT) | International Conference on Clinical Pharmacology & Therapeutics (ICCPT) | Global Summit on Drug Discovery and Development (GSDDD) | European Conference on Toxicology & Applied Pharmacology (ECTAP) | International Symposium on Experimental and Clinical Toxicology (ISECT)

Related Associations:
International Union of Basic and Clinical Pharmacology (IUPHAR) | British Pharmacological Society (BPS) | American Society for Pharmacology and Experimental Therapeutics (ASPET) | European Society of Toxicology (EUROTOX) | Society of Toxicology (SOT) | Asia Pacific Association of Pharmacologists (APAP) | Federation of Asian Pharmacological Societies (FAPS) | International Society for the Study of Xenobiotics (ISSX)

Biochemical and molecular pharmacology explore drug action at the molecular and cellular levels, focusing on receptor interactions, enzyme modulation, and signal transduction pathways. These disciplines provide the mechanistic foundation for drug discovery and development. Techniques such as molecular docking, CRISPR gene editing, and proteomics are used to identify and validate drug targets. This research helps in understanding pharmacokinetics, drug resistance, and biomarker discovery. The field also integrates systems biology to map complex drug–cell interactions, guiding the development of safer and more effective therapies.

sub tracks:

• Drug–Receptor Interactions and Signal Transduction
• Enzyme Inhibition and Activation Mechanisms
• Molecular Target Identification and Validation
• Omics Technologies in Pharmacology
• Mechanisms of Drug Resistance

Related Conferences:
World Congress on Pharmacology & Toxicology (WCPT) | International Conference on Clinical Pharmacology & Therapeutics (ICCPT) | Global Summit on Drug Discovery and Development (GSDDD) | European Conference on Toxicology & Applied Pharmacology (ECTAP) | International Symposium on Experimental and Clinical Toxicology (ISECT)

Related Associations:
International Union of Basic and Clinical Pharmacology (IUPHAR) | British Pharmacological Society (BPS) | American Society for Pharmacology and Experimental Therapeutics (ASPET) | European Society of Toxicology (EUROTOX) | Society of Toxicology (SOT) | Asia Pacific Association of Pharmacologists (APAP) | Federation of Asian Pharmacological Societies (FAPS) | International Society for the Study of Xenobiotics (ISSX)

Cardiovascular pharmacology studies drugs that affect the heart and vascular system, focusing on the treatment of conditions like hypertension, arrhythmias, heart failure, and atherosclerosis. It covers agents such as beta-blockers, ACE inhibitors, calcium channel blockers, antiplatelet, and anticoagulants. Research investigates how these drugs influence cardiac function, vascular tone, and blood clotting. Advances in molecular cardiology and targeted therapies are improving patient outcomes and reducing side effects. Cardiovascular pharmacologists also study drug safety in high-risk populations, such as the elderly or patients with multiple comorbidities.

sub tracks:

• Antihypertensive and Antiarrhythmic Agents
• Antiplatelet and Anticoagulant Therapies
• Drugs for Heart Failure and Ischemic Heart Disease
• Molecular Targets in Cardiovascular Therapy
• Safety and Efficacy in Special Populations

Related Conferences:
World Congress on Pharmacology & Toxicology (WCPT) | International Conference on Clinical Pharmacology & Therapeutics (ICCPT) | Global Summit on Drug Discovery and Development (GSDDD) | European Conference on Toxicology & Applied Pharmacology (ECTAP) | International Symposium on Experimental and Clinical Toxicology (ISECT)

Related Associations:
International Union of Basic and Clinical Pharmacology (IUPHAR) | British Pharmacological Society (BPS) | American Society for Pharmacology and Experimental Therapeutics (ASPET) | European Society of Toxicology (EUROTOX) | Society of Toxicology (SOT) | Asia Pacific Association of Pharmacologists (APAP) | Federation of Asian Pharmacological Societies (FAPS) | International Society for the Study of Xenobiotics (ISSX)

Cancer pharmacology examines the development and use of drugs to treat malignancies, while cancer toxicology evaluates their safety and side effects. The field includes chemotherapy, targeted therapies, immunotherapies, and hormone-based treatments. Researchers focus on mechanisms of action, resistance, and combination regimens to improve survival rates. Cancer toxicology addresses dose-limiting toxicities, organ damage, and secondary malignancies caused by therapy. Advances in molecular oncology and biomarker-guided treatments are driving personalized cancer care. Safety evaluation remains essential to balance therapeutic benefits with potential harm.

sub tracks:

• Chemotherapeutic Agents and Mechanisms
• Targeted and Molecularly Guided Therapies
• Immunotherapies in Oncology
• Mechanisms of Drug Resistance in Cancer
• Toxicity Management and Supportive Care

Related Conferences:
World Congress on Pharmacology & Toxicology (WCPT) | International Conference on Clinical Pharmacology & Therapeutics (ICCPT) | Global Summit on Drug Discovery and Development (GSDDD) | European Conference on Toxicology & Applied Pharmacology (ECTAP) | International Symposium on Experimental and Clinical Toxicology (ISECT)

Related Associations:
International Union of Basic and Clinical Pharmacology (IUPHAR) | British Pharmacological Society (BPS) | American Society for Pharmacology and Experimental Therapeutics (ASPET) | European Society of Toxicology (EUROTOX) | Society of Toxicology (SOT) | Asia Pacific Association of Pharmacologists (APAP) | Federation of Asian Pharmacological Societies (FAPS) | International Society for the Study of Xenobiotics (ISSX)

chemical and biological risks. These include alternative testing methods, computational toxicology, and high-throughput screening to reduce animal use. Environmental nanotoxicology, endocrine disruptors, and combined chemical exposures are areas of growing concern. Omics-based methods and AI-driven models are enhancing predictive toxicology. Researchers are also addressing global health issues like climate change–related toxin exposure and microplastic pollution. This evolving field seeks to improve accuracy, efficiency, and ethical standards in toxicity assessment.

sub tracks:

• New Approach Methodologies (NAMs) in Toxicology
• Computational and Predictive Toxicology
• Endocrine Disruptor Research
• Nano toxicology and Emerging Contaminants
• Omics and Systems Biology in Toxicology

Related Conferences:
World Congress on Pharmacology & Toxicology (WCPT) | International Conference on Clinical Pharmacology & Therapeutics (ICCPT) | Global Summit on Drug Discovery and Development (GSDDD) | European Conference on Toxicology & Applied Pharmacology (ECTAP) | International Symposium on Experimental and Clinical Toxicology (ISECT)

Related Associations:
International Union of Basic and Clinical Pharmacology (IUPHAR) | British Pharmacological Society (BPS) | American Society for Pharmacology and Experimental Therapeutics (ASPET) | European Society of Toxicology (EUROTOX) | Society of Toxicology (SOT) | Asia Pacific Association of Pharmacologists (APAP) | Federation of Asian Pharmacological Societies (FAPS) | International Society for the Study of Xenobiotics (ISSX)

Food and nutritional toxicology examines the safety of food components, additives, contaminants, and natural toxins. It assesses both acute and chronic health effects from dietary exposures. Topics include mycotoxins, pesticide residues, heavy metals, foodborne pathogens, and the toxicology of food processing by products. This field also studies nutrient–drug interactions and the safety of dietary supplements. Regulatory agencies rely on food toxicology data to establish safe intake limits and labelling requirements. Advances in detection methods and risk assessment tools are improving food safety globally.

sub tracks:

• Mycotoxins and Natural Foodborne Toxins
• Pesticide and Chemical Residues in Food
• Heavy Metals in the Food Chain
• Nutrient–Drug Interactions
• Safety Assessment of Functional Foods and Supplements

Related Conferences:
World Congress on Pharmacology & Toxicology (WCPT) | International Conference on Clinical Pharmacology & Therapeutics (ICCPT) | Global Summit on Drug Discovery and Development (GSDDD) | European Conference on Toxicology & Applied Pharmacology (ECTAP) | International Symposium on Experimental and Clinical Toxicology (ISECT)

Related Associations:
International Union of Basic and Clinical Pharmacology (IUPHAR) | British Pharmacological Society (BPS) | American Society for Pharmacology and Experimental Therapeutics (ASPET) | European Society of Toxicology (EUROTOX) | Society of Toxicology (SOT) | Asia Pacific Association of Pharmacologists (APAP) | Federation of Asian Pharmacological Societies (FAPS) | International Society for the Study of Xenobiotics (ISSX)

Pharmacological approaches to COVID-19 encompass drug development, repurposing, and optimization strategies for prevention and treatment. This includes antiviral agents, immunomodulatory, monoclonal antibodies, and supportive therapies. Clinical research has rapidly evolved to identify effective treatments for different stages of the disease. Pharmacology also plays a role in vaccine adjuvant design, pharmacokinetics of antiviral combinations, and management of post-COVID complications. Ongoing studies address emerging variants, resistance, and long-term safety of COVID-19 therapeutics.

Sub tracks:

• Antiviral Agents and Combination Therapies
• Immunomodulatory in COVID-19 Management
• Drug Repurposing for SARS-CoV-2
• Pharmacology of COVID-19 Vaccines
• Treatment of Long COVID and Post-Infection Syndromes

Related Conferences:
World Congress on Pharmacology & Toxicology (WCPT) | International Conference on Clinical Pharmacology & Therapeutics (ICCPT) | Global Summit on Drug Discovery and Development (GSDDD) | European Conference on Toxicology & Applied Pharmacology (ECTAP) | International Symposium on Experimental and Clinical Toxicology (ISECT)

Related Associations:
International Union of Basic and Clinical Pharmacology (IUPHAR) | British Pharmacological Society (BPS) | American Society for Pharmacology and Experimental Therapeutics (ASPET) | European Society of Toxicology (EUROTOX) | Society of Toxicology (SOT) | Asia Pacific Association of Pharmacologists (APAP) | Federation of Asian Pharmacological Societies (FAPS) | International Society for the Study of Xenobiotics (ISSX)

Case studies in pharmacology provide real-world examples of drug action, therapeutic challenges, and clinical decision-making. They illustrate how pharmacological principles are applied in diagnosis, treatment planning, and patient safety management. Case-based learning enhances understanding of drug interactions, adverse events, and personalized medicine strategies. These studies are valuable for education, professional training, and identifying areas for research. Well-documented case reports contribute to pharmacovigilance and clinical best practices.

sub tracks:

• Case Reports on Drug Efficacy and Failure
• Clinical Management of Adverse Drug Reactions
• Rare Diseases and Orphan Drug Use
• Pharmacokinetic Challenges in Special Populations
• Ethical and Legal Issues in Pharmacological Practice

Related Conferences:
World Congress on Pharmacology & Toxicology (WCPT) | International Conference on Clinical Pharmacology & Therapeutics (ICCPT) | Global Summit on Drug Discovery and Development (GSDDD) | European Conference on Toxicology & Applied Pharmacology (ECTAP) | International Symposium on Experimental and Clinical Toxicology (ISECT)

Related Associations:
International Union of Basic and Clinical Pharmacology (IUPHAR) | British Pharmacological Society (BPS) | American Society for Pharmacology and Experimental Therapeutics (ASPET) | European Society of Toxicology (EUROTOX) | Society of Toxicology (SOT) | Asia Pacific Association of Pharmacologists (APAP) | Federation of Asian Pharmacological Societies (FAPS) | International Society for the Study of Xenobiotics (ISSX)

Recent advances in pharmacology encompass innovations in drug discovery, delivery systems, and therapeutic strategies. This includes breakthroughs in gene therapy, CRISPR-based treatments, RNA therapeutics, and precision medicine. Novel drug delivery platforms such as 3D-printed dosage forms and smart nanoparticles are enhancing bioavailability and targeting. Advances in computational drug design, AI-based screening, and organ-on-chip models are accelerating the pipeline from discovery to market. The field is also embracing sustainability, green chemistry, and global health perspectives in drug development.

sub tracks:

• Gene and RNA-Based Therapeutics
• AI and Machine Learning in Drug Discovery
• Smart and Targeted Drug Delivery Systems
• Organ-on-Chip and In Vitro Modeling
• Sustainable and Green Pharmacology Practices

Related Conferences:
World Congress on Pharmacology & Toxicology (WCPT) | International Conference on Clinical Pharmacology & Therapeutics (ICCPT) | Global Summit on Drug Discovery and Development (GSDDD) | European Conference on Toxicology & Applied Pharmacology (ECTAP) | International Symposium on Experimental and Clinical Toxicology (ISECT)

Related Associations:
International Union of Basic and Clinical Pharmacology (IUPHAR) | British Pharmacological Society (BPS) | American Society for Pharmacology and Experimental Therapeutics (ASPET) | European Society of Toxicology (EUROTOX) | Society of Toxicology (SOT) | Asia Pacific Association of Pharmacologists (APAP) | Federation of Asian Pharmacological Societies (FAPS) | International Society for the Study of Xenobiotics (ISSX)